Skip to content
ppharmaranks
Menu

KISQALI vs VONJO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. KISQALI and VONJO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

70/100
New

Pharmacy pays

Type

RX
RX

Active ingredient

RIBOCICLIB SUCCINATE
PACRITINIB CITRATE

Manufacturer

Dosage forms

Tablet
Capsule

Drug class

Kinase Inhibitor
Kinase Inhibitor

Boxed warning

None
None

Treats

Breast Neoplasms
Primary Myelofibrosis

Frequently asked questions

What is the difference between Kisqali and Vonjo?

Kisqali contains Ribociclib Succinate, while Vonjo contains Pacritinib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.